Auftraggeberprofil
European Centre for Disease Prevention and Control (ECDC)
SE- Vergaben
- 44
- Vergebener Gesamtwert
- 169.020.599 €
- Länder
- Schweden
- Letzte Vergabe
- 31.05.2024
- Ablauf innerhalb von 12 Monaten
- 0
Vergabehistorie
| Datum | Anbieter | Titel | Kategorie | Auftragswert | Land | Läuft ab | Quelle |
|---|---|---|---|---|---|---|---|
| 31.05.2024 | Sweden-Solna: Medical Services – OJ/2023/RMS/25575 | — | 720.000,0 € | SE | — | Auf TED ansehen ↗ | |
| 07.03.2024 | Sweden-Solna: Artificial Intelligence for Surveillance and Other Core Public Health Functions – OJ/2023/PHF/26497 | — | 6,5 Mio. € | SE | — | Auf TED ansehen ↗ | |
| 13.02.2024 | Sweden-Solna: Estimating the Burden of Tuberculosis Infection in the EU/EEA – OJ/2023/DPR/26040 | — | 950.000,0 € | SE | — | Auf TED ansehen ↗ | |
| 30.01.2024 | Sweden-Solna: Vaccine Effectiveness, Burden and Impact Studies (VEBIS) of COVID-19 and Influenza | — | 6,7 Mio. € | SE | — | Auf TED ansehen ↗ | |
| 23.01.2024 | Sweden-Solna: Support to Microbiology-related Activities and Capacity Building Focusing on COVID-19 and Influenza in the EU/EEA, the Western Balkans and Turkey Laboratory Support, Training, and Standardisation | — | 6,1 Mio. € | SE | — | Auf TED ansehen ↗ | |
| 15.12.2023 | Sweden-Solna: Artificial Intelligence for Surveillance and Other Core Public Health Functions – OJ/2023/PHF/26497 | — | 6,5 Mio. € | SE | — | Auf TED ansehen ↗ | |
| 05.12.2023 | Sweden-Solna: Medical Services | — | 720.000,0 € | SE | — | Auf TED ansehen ↗ | |
| 14.11.2023 | Sweden-Solna: Lot 1: Literature Reviews and Rapid Reviews on Topics Related to Public Health Emergency Preparedness and Response – OJ/2022/PHF/24511 | — | 2,4 Mio. € | SE | — | Auf TED ansehen ↗ | |
| 13.09.2023 | Sweden-Solna: European Men-Who-Have-Sex-With-Men Internet Survey Country-level Promotion and European Analysis | — | 600.000,0 € | SE | — | Auf TED ansehen ↗ | |
| 21.07.2023 | Sweden-Solna: Sentinel Surveillance for Hepatitis B and C – OJ/2022/DPR/25150 | — | 1,4 Mio. € | SE | — | Auf TED ansehen ↗ | |
| 12.07.2023 | Sweden-Solna: Biostatistics Services – OJ/2022/SMS/24218 | — | 3,5 Mio. € | SE | — | Auf TED ansehen ↗ | |
| 10.07.2023 | Sweden-Solna: Literature Reviews and Rapid Reviews on Topics Related to Public Health Emergency Preparedness and Response – OJ/2022/PHF/24511 | — | 1,5 Mio. € | SE | — | Auf TED ansehen ↗ | |
| 04.07.2023 | Sweden-Solna: European Gonococcal Antimicrobial Surveillance Programme – OJ/2022/DPR/13434 | Medizinische Dienstleistungen | 1,2 Mio. € | SE | — | Auf TED ansehen ↗ | |
| 05.06.2023 | Sweden-Solna: Organisation and Implementation of Professional Exchange Visits of Public Health Experts in the European Union (EU) and European Economic Area (EEA) – OJ/2023/PHF/26496 | — | — | SE | — | Auf TED ansehen ↗ | |
| 17.05.2023 | Sweden-Solna: Centralised Laboratory Support | — | 1,0 Mio. € | SE | — | Auf TED ansehen ↗ | |
| 04.05.2023 | Sweden-Solna: Information Management Services - OJ/2023/SMS/26473 | — | 2,9 Mio. € | SE | — | Auf TED ansehen ↗ | |
| 14.03.2023 | Sweden-Solna: Support to Microbiology-related Activities and Capacity Building Focusing on COVID-19 and Influenza in the EU/EEA, the Western Balkans and Turkey Laboratory Support, Training, and Standardisation | — | 6,1 Mio. € | SE | — | Auf TED ansehen ↗ | |
| 29.12.2022 | Sweden-Solna: Excess Mortality Monitoring in Europe to Assess Impact of Communicable Diseases | — | 1,8 Mio. € | SE | — | Auf TED ansehen ↗ | |
| 29.12.2022 | Sweden-Solna: Genomic Epidemiology and Public Health Bioinformatics Trainings in the EU/EEA, the Western Balkans and Turkey | — | 5,2 Mio. € | SE | — | Auf TED ansehen ↗ | |
| 15.12.2022 | Sweden-Solna: Country Support to Advance One-Health Responses against Antimicrobial Resistance in Western Balkans | — | 300.000,0 € | SE | — | Auf TED ansehen ↗ | |
| 21.10.2022 | Sweden-Solna: European Standards of HIV Care | — | 499.800,0 € | SE | — | Auf TED ansehen ↗ | |
| 04.10.2022 | Sweden-Solna: Coordination of the European Reference Laboratory Network for Pertussis | Medizinische Dienstleistungen | 300.000,0 € | SE | — | Auf TED ansehen ↗ | |
| 04.10.2022 | Sweden-Solna: External Quality Assessment (EQA) Schemes for Supporting the Surveillance of Legionnaires’ Disease at European Level | Labor & Diagnostik | 400.000,0 € | SE | — | Auf TED ansehen ↗ | |
| 03.10.2022 | Sweden-Solna: Monitoring the HIV and Viral Hepatitis Response in Europe and Neighbouring Countries | Medizinische Dienstleistungen | 600.000,0 € | SE | — | Auf TED ansehen ↗ | |
| 03.10.2022 | Sweden-Solna: Assessment of New Technologies for Infectious Disease Surveillance, Prevention and Control | Gesundheits-IT & Software | 1,2 Mio. € | SE | — | Auf TED ansehen ↗ | |
| 03.10.2022 | Sweden-Solna: Assessing the Risk of Fungal and Parasitic Diseases Transmission by Substances of Human Origin | Labor & Diagnostik | 180.000,0 € | SE | — | Auf TED ansehen ↗ | |
| 26.09.2022 | Sweden-Solna: Standardisation of Antimicrobial Susceptibility Testing Methods and Development of Clinical Breakpoints for Surveillance of Antimicrobial Resistance in Europe | — | 600.000,0 € | SE | — | Auf TED ansehen ↗ | |
| 26.09.2022 | Sweden-Solna: Medical Services | — | 600.000,0 € | SE | — | Auf TED ansehen ↗ | |
| 21.09.2022 | Sweden-Solna: Assessing the Vulnerabilities and Impact of COVID-19 in Migrants and Ethnic Minorities in the EU/EEA and the UK | — | 50.000,0 € | SE | — | Auf TED ansehen ↗ | |
| 21.09.2022 | Sweden-Solna: External Quality Assessment of Molecular Typing of Salmonella, STEC and Listeria | — | 660.000,0 € | SE | — | Auf TED ansehen ↗ | |
| 21.09.2022 | Sweden-Solna: Developing an Infrastructure and Performing Vaccine Effectiveness Studies for COVID-19 Vaccine in the EU/EEA | — | 1,7 Mio. € | SE | — | Auf TED ansehen ↗ | |
| 21.09.2022 | Sweden-Solna: COVID‐19 High‐capacity, High‐priority Whole Genome Sequencing Support‐FWC | — | 48,2 Mio. € | SE | — | Auf TED ansehen ↗ | |
| 21.09.2022 | Sweden-Solna: Laboratory Support for Seroepidemiology Studies | — | 234.541,0 € | SE | — | Auf TED ansehen ↗ | |
| 21.09.2022 | Sweden-Solna: Scientific Support to Data Analysis and Coordination Activities of the European Surveillance of Antimicrobial Consumption Network (ESAC-Net) | — | 260.000,0 € | SE | — | Auf TED ansehen ↗ | |
| 21.09.2022 | Sweden-Solna: External Quality Assessment of Performance of Laboratories Participating in European Antimicrobial Resistance Surveillance Network (EARS-Net) | — | 610.000,0 € | SE | — | Auf TED ansehen ↗ | |
| 21.09.2022 | Sweden-Solna: Supporting EU Member States in Conducting Hepatitis C Prevalence Surveys | — | 480.000,0 € | SE | — | Auf TED ansehen ↗ | |
| 21.09.2022 | Sweden-Solna: Establishing Severe Acute Respiratory Infections (SARI) Surveillance and Performing Hospital-based COVID-19 Transmission Studies | — | 2,3 Mio. € | SE | — | Auf TED ansehen ↗ | |
| 21.01.2022 | Sweden-Solna: Country Support for the Prevention and Control of HIV/AIDS, Sexually Transmitted Infections and Viral Hepatitis in EU/EEA Countries | — | 1,0 Mio. € | SE | — | Auf TED ansehen ↗ | |
| 28.12.2021 | Sweden-Solna: Scientific Support to Data Analysis and Coordination Activities of the European Surveillance of Antimicrobial Consumption Network (ESAC-Net) | — | 260.000,0 € | SE | — | Auf TED ansehen ↗ | |
| 29.10.2021 | Sweden-Solna: Vaccine Effectiveness, Burden and Impact Studies (VEBIS) of COVID-19 and Influenza | — | 50,2 Mio. € | SE | — | Auf TED ansehen ↗ | |
| 24.09.2021 | Sweden-Solna: External Quality Assessment of Molecular Typing of Salmonella, STEC and Listeria | — | 660.000,0 € | SE | — | Auf TED ansehen ↗ | |
| 24.09.2021 | Sweden-Solna: Support to Microbiology-related Activities and Capacity Building Focusing on COVID-19 and Influenza in the EU/EEA, the Western Balkans and Turkey. Laboratory Support, Training, and Standardisation | — | — | SE | — | Auf TED ansehen ↗ | |
| 15.09.2021 | Sweden-Solna: Vaccine Effectiveness, Burden and Impact Studies (VEBIS) of COVID-19 and Influenza | — | — | SE | — | Auf TED ansehen ↗ | |
| 15.09.2021 | Sweden-Solna: Enhanced laboratory support to perform assessment of vaccine effectiveness against SARS-CoV-2 infection | — | 2,0 Mio. € | SE | — | Auf TED ansehen ↗ |